Digipath
CHM Cannabis
Home > Boards > US OTC > Delisted >

EP Global Communications, Inc. (fka EPGL)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, Stocking Barber
Search This Board: 
Last Post: 12/12/2018 10:53:59 AM - Followers: 476 - Board type: Free - Posts Today: 1

 
   

EPGL MED is now InWith Corp - A Private Company

 


People, Products & Process:

EPGL is structuring an up-coming relationship with a new start-up company called InWith Corporation, to begin in January 2017, for the purpose of building selected EPGL technologies.  As of 11/21/17 this has not happened and there has been no furthur update.

EPGL has now received multiple USPTO patent allowances. EPGL expects to report within the next quarterly update, a decision from USPTO on any additional patent allowance(s). EPGL will inform our shareholders via public release immediately upon receiving such notice from the USPTO .

On April 12, 2016 EPGL signed an Agreement with Johnson & Johnson Vision Care, Inc. (JNJVC) . EPGL has several patents now pending in the field of ophthalmic technologies, specifically the integration of electronics into contact lenses for vision correction and augmented vision applications. JNJVC has secured exclusive rights of first negotiation to all EPGL ophthalmic technologies and patents pending. EPGL has received three (3) USPTO patent allowances since our last updated disclosure.

EPGL and CooperVision, Inc. reached a Settlement Agreement in December 2015. In December 2014, CooperVision, Inc. asked EPGL to grant the Exclusive Option to license EPGL jointly developed ophthalmic technologies. EPGL refused to do so, contending that the Development Agreement was breached and did not allow the granting of the Option for several more months after all joint IP was fully filed. EPGL threatened litigation over the issue. In May 2015, CooperVision, Inc. suggested mediation and EPGL agreed to do so. As announced publicly in a jointly approved January 2016 PR, after several months of negotiations, a settlement was reached whereby, to avoid litigation, the parties would agree that CooperVision, Inc. will retain rights and license to use the joint technology in their products in exchange for an undisclosed cash payment and EPGL receiving assignment of the IP and 100% ownership control and marketing rights worldwide.

EP Global Communications, Inc., is a research and development company with focus on medical device design, ophthalmic medical device design, consumer electronic device design and device technologies in the IoT space.

In 2014, all EPGL technologies and Intellectual property were selected and put under Development Agreement by CooperVision, Inc., a leading medical device manufacturer, for development and marketing. The EPGL team is now securing Intellectual Properties and co-developing a family of advanced devices as a result. This Development Agreement was publicly disclosed on August 29, 2014. In addition, EPGL has entered an initial Agreement with Intel Corporation. EPGL has also entered into Agreements with AT&T as of January 2015. EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties.

EPGL Medical is the result of a reorganization which culminated in July 2012. With a strong team of medical and scientific professionals, the Company is poised to capture market share with innovative "smart medical and consumer electronic devices" technologies including those that require advanced microelectronic mechanical systems (MEMS). The Company philosophy is that healthcare is going

to become an increasingly challenging environment for both physicians and patients. A coming boom in patients simultatneous to a possible shortage of physicians will necessitate intuitive medical devices which can be used by a broader variety of doctors. In short, new "smart medical devices" advanced research and design intellectual properties will be needed more than ever. EPGL Medical has the know-how to develop technologies which fit this coming new healthcare environment and enable industry leaders to capture market share with those advanced technologies.

EP Global Communications, Inc. dba EPGL Medical, is a Delaware Corporation first incorporated November 17, 1999.


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.
 

For more Information Visit https://portal.USPTO.GOV ALSO VISIT The World Intellectual Property Organization http://www.wipo.int/portal/en/index.html for information on REAL IP related to EP Global Communications DBA EPGL Medical
Below is a list of pending or granted IP that has been published

 
***. 3167695 ELASTIC CIRCUIT EP 17.05.2017
  .
 
15818698 MARKUS DAVID MARKUS DAVID
The present invention is an elastic electronic circuit adapted to provide three-dimensional elasticity. This is accomplished through a first pattern, a second pattern embedded within the first pattern, and a third pattern. The three-dimension elastic electronic circuit is adapted to conform to a flexible substrate, such as flexible plastic substrates and the like. The resulting three-dimensional elasticity enables the use of electronic circuits on such flexible substrates.
 
. 3123237 SYSTEM AND METHOD FOR CONTACT LENS WIRELESS COMMUNICATION EP 01.02.2017
G02C 7/04
 
 
15768969 MARKUS DAVID MARKUS DAVID
 
The present invention will provide a vision correction device which makes use of wireless transmissions and/or wireless charging to transfer data between the vision correction device and an external device. More specifically, the present invention will incorporate radio frequency technology onto a contact lens, including passive and active embodiments, and may further include wireless charging capability. This is accomplished by positioning an extremely small RF device onto a contact lens, along with an antenna and/or battery, and using a fluid medium to enhance the signal to and from an external device.

3104810 PIEZOELECTRIC SENSOR FOR VISION CORRECTION
EP 21.12.2016
A61F 2/16
 .
 
15749280 MARKUS DAVID MARKUS DAVID
 
The present invention will provide a vision correction device which utilizes the movements of the eye to correct the focus of the user without the need of surgical procedures. More specifically, the present invention will detect the movement of the ciliary muscle and adaptively modify the shape of an artificial lens positioned inside or outside of the eye to adjust the focus of the lens. This adjustment will occur very rapidly and coincide with the ciliary muscles attempt to focus the crystalline lens of the eye
 
 
WO/2016/161463 METHOD AND APPARATUS FOR AN IMAGING LENS WO 06.10.2016
G02C 7/02
 
 
PCT/US2016/025947 MARKUS, David MARKUS, David
 
The present invention is a method and apparatus projecting an image or series of images onto the retina. Furthermore, the present invention is neither cumbersome nor obstructive to the user. This is accomplished by embedding an imaging lens on the perimeter of the contact lens adapted to project an image inward toward the center of the contact lens, wherein the projected light will then be redirected onto the retina
 
WO/2016/073446 METHOD AND APPARATUS FOR AN ADAPTIVE FOCUS LENS WO 12.05.2016
G02B 3/14
.
 
PCT/US2015/058783 COOPERVISION INTERNATIONAL HOLDING COMPANY, LP MARKUS, David T.
 
Methods and apparatus are provided for adaptively focusing a lens. In one approach, electromagnetic energy is employed to modify a shape or thickness of a lens such that its refractive power and focal length are modified. In one aspect, a lens embodying adaptive focus features requires low power, and can be adjusted quickly. One or a plurality of electromagnets can be employed to compress or separate end portions of an embedded haptic, the force from which acts to alter the shape of the haptic, thus modifying the refractive power and focal length of a lens.
 
WO/2016/048941 MEDICAL DEVICE WITH PRE-DEFINED SPACE AND RELATED METHODS WO 31.03.2016
G02C 7/04
.
 
PCT/US2015/051321 EP GLOBAL COMMUNICATIONS, INC. MARKUS, David T.
 
A medical device including a pre-defined space such as a geometric shape or void. In one approach, the pre-defined space provides desired rigidity and more confort for a user. There is also provided an approach which enables engravings and accommodates electronics, mechanical objects, or other rigid or unique shapes to be embedded within a medical device such as a contact lens. When adapted to swellable substrates, the resulting swelled material can leave a gap around a perimeter of embbedded structure.
 
WO/2016/022665 ELECTRONIC MEDICAL DEVICES AND METHODS WO 11.02.2016
G02C 7/04
 
 
PCT/US2015/043783 EP GLOBAL COMMUNICATIONS, INC. MARKUS, David T.
 
The present disclosure provides an elastic electronic circuit adapted to provide three-dimensional elasticity while conforming to the curved or angled structures of a swellable medical device, such as a hydrogel or silicone hydrogel contact lens. The elastic electronic circuit can include a first pattern for flexibility in a first dimension, a second pattern for flexibility in a second dimension, and a third pattern for flexiblility in a third dimension. Alternatively, the elastic circuit can include a first pattern for flexibility in a first dimension and a second pattern for flexibility in a second dimension. The resulting three-dimensional elasticity enables the use of electronic circuits on soft contact lenses, where manufacture and use will cause the lenses and circuits to swell and shrink. Furthermore, the electronic circuit will not distort the vision correction of the contact lens or othwerwise cause discomfort or other negative side effects.
 
20160030160 Piezoelectric sensor for vision correction US 04.02.2016
G02C 7/08
.
 
14622814 David T. Markus David T. Markus
 

The present invention will provide a vision correction device which utilizes the movements of the eye to correct the focus of the user without the need of surgical procedures. More specifically, the present invention will detect the movement of the ciliary muscle and adaptively modify the shape of an artificial lens positioned inside or outside of the eye to adjust the focus of the lens. This adjustment will occur very rapidly and coincide with the ciliary muscle's attempt to focus the crystalline lens of the eye.

 
WO/2016/014118 PIEZOELECTRIC ENERGY HARVESTING CONTACT LENS WO 28.01.2016
A61B 3/16
.
 
PCT/US2015/015516 MARKUS, David MARKUS, David
 
The present invention will provide a piezoelectric energy-harvesting device in a contact lens that utilizes the multiplicity of constant forces generated by the eye for generating usable energy. The present invention will place a plurality of piezoelectric microdevices in direct or indirect contact with the eye, with the preferred embodiment in the form of a contact lens comprising an array of piezoelectric microdevices at the perimeter of a contact lens. These piezoelectric microdevices will harvest electrical energy generated by the mechanical forces applied by the various activities and movements of the eye, including, but not limited to, winking, squinting, blinking, rolling of the eyes, and vibration of the eyes.
 
20160014889 Elastic circuit US 14.01.2016
H05K 1/00
..
 
14794789 David T. Markus David T. Markus
 

The present invention is an elastic electronic circuit adapted to provide three-dimensional elasticity. This is accomplished through a first pattern, a second pattern embedded within the first pattern, and a third pattern. The three-dimension elastic electronic circuit is adapted to conform to a flexible substrate, such as flexible plastic substrates and the like. The resulting three-dimensional elasticity enables the use of electronic circuits on such flexible substrates.
 

WO/2016/007683 ELASTIC CIRCUIT WO 14.01.2016
H05K 1/02
 
 
PCT/US2015/039626 MARKUS, David MARKUS, David
 
The present invention is an elastic electronic circuit adapted to provide three-dimensional elasticity. This is accomplished through a first pattern, a second pattern embedded within the first pattern, and a third pattern. The three-dimension elastic electronic circuit is adapted to conform to a flexible substrate, such as flexible plastic substrates and the like. The resulting three-dimensional elasticity enables the use of electronic circuits on such flexible substrates.
 
20150281411 System for contact lens wireless communication US 01.10.2015
H04B 1/00
 
 
14668957 David T. Markus David T. Markus
 

The present invention will provide a vision correction device which makes use of wireless transmissions and/or wireless charging to transfer data between the vision correction device and an external device. More specifically, the present invention will incorporate radio frequency technology onto a contact lens, including passive and active embodiments, and may further include wireless charging capability. This is accomplished by positioning an extremely small RF device onto a contact lens, along with an antenna and/or battery, and using a fluid medium to enhance the signal to and from an external device.
 

WO/2015/148735 SYSTEM AND METHOD FOR CONTACT LENS WIRELESS COMMUNICATION WO 01.10.2015
G02C 7/04
 
 
PCT/US2015/022591 MARKUS, David MARKUS, David
 
The present invention will provide a vision correction device which makes use of wireless transmissions and/or wireless charging to transfer data between the vision correction device and an external device. More specifically, the present invention will incorporate radio frequency technology onto a contact lens, including passive and active embodiments, and may further include wireless charging capability. This is accomplished by positioning an extremely small RF device onto a contact lens, along with an antenna and/or battery, and using a fluid medium to enhance the signal to and from an external device.
 
WO/2015/123616 PIEZOELECTRIC SENSOR FOR VISION CORRECTION WO 20.08.2015
A61F 2/16
 
 
PCT/US2015/015978 MARKUS, David MARKUS, David
 
The present invention will provide a vision correction device which utilizes the movements of the eye to correct the focus of the user without the need of surgical procedures. More specifically, the present invention will detect the movement of the ciliary muscle and adaptively modify the shape of an artificial lens positioned inside or outside of the eye to adjust the focus of the lens. This adjustment will occur very rapidly and coincide with the ciliary muscles attempt to focus the crystalline lens of the eye.
 
The Company claims to have significant know-how and Intellectual Property in the arena of BioMEMS and claims to have invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 


 


The Company claims to have leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. 
***************************************************************************************************************************************************************************************************
Helpful links to EPGL and the companies that are involved 


EPGL Medical  https://www.epglmed.com
InWith Corporation  
http://www.inwithcorp.com/
CooperVision https://coopervision.com/ Devloped Joint IP with EPGL Medical, (reference) A. Back in filings
Wilson Sonsini Goodrich & Rosati https://www.wsgr.com/WSGR/Default.aspx 
Pricewaterhousecoopers http://www.pwc.com/ Major shareholder requested this and granted by courts
Johnson & Johnson http://www.jnjvc.com/ Holding first rights to EPGL technologies
AT&T  https://www.att.com/ Joint IP developed with EPGL, anticiapte to see publications MID 2017


Share Structure Prior to going PRIVATE:
Authorized Shares 5,000,000,000 a/o Nov 21, 2017 
Outstanding Shares 4,901,568,146 a/o Nov 21, 2017 
Restricted 2,532,562,942 a/o Oct 11, 2017 
Unrestricted 2,336,005,204 a/o Oct 11, 2017 
Held at DTC 653,285,993 a/o Nov 21, 2017 
Float 499,161,167 a/o Mar 31, 2016 

 










 

 

Digipath
CHM Cannabis
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#127359  Sticky Note Has the company stated what the reverse split Stocking Barber 01/23/18 09:17:41 AM
#108787  Sticky Note EPGL Wins Allowance on First Patent vikingzskillz 08/30/16 10:08:17 PM
#95482  Sticky Note Press releases or other company communication should not IH Brian (Retired) 01/12/16 12:14:18 PM
#130499   Some good reading for some EPGL-lovers. Donguri 12/12/18 10:53:59 AM
#130496   He was even before EPGL! Stocking Barber 12/10/18 03:07:44 PM
#130495   Bunnyman appears to be a skilled con man.... Atlanta1 12/10/18 03:01:13 PM
#130494   And he also said that the MPDD would Stocking Barber 12/10/18 02:58:52 PM
#130493   but wait - didn't Bunnyman say it was Atlanta1 12/10/18 02:44:11 PM
#130492   I'm lowering my asking price to $1.50 per jhnvtjll 12/10/18 02:09:09 PM
#130491   I'm lowering my asking price to $2.00 per jhnvtjll 12/07/18 10:29:15 PM
#130490   Quote ??????? Do you mean that Inwith made recently kura 12/07/18 09:59:52 PM
#130489   Maybe most InWith longs don't have internet connections Stocking Barber 12/06/18 03:24:50 PM
#130488   I'm lowering my asking price to $3.50 per jhnvtjll 12/06/18 03:22:27 PM
#130487   ok - thanks. for a moment there I Atlanta1 12/06/18 09:27:22 AM
#130486   LOL..... actually no. Just kidding. I Hank Kerchief 12/06/18 09:13:23 AM
#130484   Best time to buy private shares is now jhnvtjll 12/06/18 09:05:39 AM
#130483   LOL.....bbbbbbbut there is always a chance of recovery Hank Kerchief 12/06/18 09:02:32 AM
#130482   seriously?? roflmfao Atlanta1 12/06/18 07:43:05 AM
#130481   ??????? Do you mean that Inwith made recently Koog 12/05/18 02:01:03 PM
#130480   LOL! Today's volume with the market closed matches every Stocking Barber 12/05/18 01:53:50 PM
#130479   Is anyone buying on the dips especially since Hank Kerchief 12/05/18 01:14:24 PM
#130478   I'm asking $4 per share, plus an additional jhnvtjll 12/04/18 06:03:22 PM
#130477   $4 for your shares ? I buy, franck92 12/04/18 04:56:30 PM
#130476   The shares are worth $4 because that's my jhnvtjll 12/04/18 04:38:42 PM
#130475   By my calculations that puts Inwith worth about alan81 12/04/18 03:49:16 PM
#130474   ??????? Do you mean that Inwith made recently franck92 12/04/18 03:33:05 PM
#130473   LOL! The shares are worthless unless some ill-informed chump Stocking Barber 12/04/18 12:52:57 PM
#130472   What's up? Broadrige Financial says To sell your bubbas11 12/04/18 12:43:33 PM
#130471   Very True MarkHart66 12/04/18 07:36:45 AM
#130470   I suspected exactly what you were talking about 4u2nv2 12/03/18 10:06:19 PM
#130468   It will trade the day after....on the imaginary sheets. jhnvtjll 12/01/18 05:36:08 PM
#130467   Or ever again... Stocking Barber 12/01/18 05:20:42 PM
#130466   EPGL won't be trading on Wednesday. jhnvtjll 12/01/18 04:58:45 PM
#130465   Tomorrow is December 1st. Could be a jhnvtjll 11/30/18 06:48:54 PM
#130464   Apparently Bunnyman doesn't think they will sue... Stocking Barber 11/30/18 06:06:15 PM
#130463   What about those without Facebook? jhnvtjll 11/29/18 04:06:46 PM
#130462   Had you indicated interest? Stocking Barber 11/29/18 01:44:29 PM
#130461   I received this email this morning from InWith MarkHart66 11/29/18 12:59:39 PM
#130460   No one ever answered me about where ALL MarkHart66 11/29/18 09:19:36 AM
#130459   The Wall Street Journal writer who mentioned $InWith jhnvtjll 11/28/18 06:11:59 PM
#130458   EPGL is the real deal. Time to jhnvtjll 11/28/18 05:36:21 PM
#130454   Yeah, but there is less skim if you alan81 11/27/18 03:18:20 PM
#130453   Very low volume here today. Must be jhnvtjll 11/27/18 03:05:35 PM
#130452   I sure hope it isn't bunnyman in the centerfold! Stocking Barber 11/27/18 03:05:06 PM
#130451   I can't wait to see the Super 8-K jhnvtjll 11/27/18 03:03:18 PM
#130450   Thank You. LOVE*PINK 11/27/18 08:43:48 AM
#130449   100% WRONG StockBarber. Many EPGL and PennyStock investors LOVE*PINK 11/27/18 08:40:54 AM
#130448   I was right once again! jhnvtjll 11/26/18 07:25:48 PM
#130447   I put in a sell order at $1.00 jhnvtjll 11/26/18 05:55:06 PM
#130446   I’ve been in a delisted stock that has Quindien 11/26/18 03:15:38 PM
#130445   Whew!!...I've seen delisted stocks discussed as if they'll The Grinch 11/26/18 03:14:37 PM
#130444   Agree! jhnvtjll 11/26/18 03:12:57 PM
#130443   They gave plenty of time to sell before jhnvtjll 11/26/18 03:11:52 PM
PostSubject